These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15760650)
1. The regulation of beta-secretase by cholesterol and statins in Alzheimer's disease. Sidera C; Parsons R; Austen B J Neurol Sci; 2005 Mar; 229-230():269-73. PubMed ID: 15760650 [TBL] [Abstract][Full Text] [Related]
2. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907 [TBL] [Abstract][Full Text] [Related]
3. The role of intracellular cholesterol on the processing of the beta-amyloid precursor protein. Austen BM; Sidera C; Liu C; Frears E J Nutr Health Aging; 2003; 7(1):31-6. PubMed ID: 12679838 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the lipidation of beta-secretase by statins. Parsons RB; Farrant JK; Price GC; Subramaniam D; Austen BM Biochem Soc Trans; 2007 Jun; 35(Pt 3):577-82. PubMed ID: 17511656 [TBL] [Abstract][Full Text] [Related]
5. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease. Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054 [TBL] [Abstract][Full Text] [Related]
6. A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets. Liu WW; Todd S; Coulson DT; Irvine GB; Passmore AP; McGuinness B; McConville M; Craig D; Johnston JA J Neurochem; 2009 Jan; 108(2):341-9. PubMed ID: 19094065 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol and Alzheimer's disease--is there a relation? Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384 [TBL] [Abstract][Full Text] [Related]
8. Post-translational processing of beta-secretase in Alzheimer's disease. Sidera C; Parsons R; Austen B Proteomics; 2005 Apr; 5(6):1533-43. PubMed ID: 15789346 [TBL] [Abstract][Full Text] [Related]
9. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease. Pollack SJ; Lewis H Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602 [TBL] [Abstract][Full Text] [Related]
10. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373 [TBL] [Abstract][Full Text] [Related]
12. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. Kojro E; Füger P; Prinzen C; Kanarek AM; Rat D; Endres K; Fahrenholz F; Postina R J Alzheimers Dis; 2010; 20(4):1215-31. PubMed ID: 20413873 [TBL] [Abstract][Full Text] [Related]
13. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. Kaether C; Haass C J Cell Biol; 2004 Dec; 167(5):809-12. PubMed ID: 15583026 [TBL] [Abstract][Full Text] [Related]
14. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain. Stockley JH; Ravid R; O'Neill C FEBS Lett; 2006 Dec; 580(28-29):6550-60. PubMed ID: 17113083 [TBL] [Abstract][Full Text] [Related]
15. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice. Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Holsinger RM; McLean CA; Beyreuther K; Masters CL; Evin G Ann Neurol; 2002 Jun; 51(6):783-6. PubMed ID: 12112088 [TBL] [Abstract][Full Text] [Related]
17. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887 [TBL] [Abstract][Full Text] [Related]
18. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages. Lefranc-Jullien S; Sunyach C; Checler F J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370 [TBL] [Abstract][Full Text] [Related]
19. CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Zhou S; Zhou H; Walian PJ; Jap BK Proc Natl Acad Sci U S A; 2005 May; 102(21):7499-504. PubMed ID: 15890777 [TBL] [Abstract][Full Text] [Related]